Search by Drug Name or NDC
NDC 28595-0570-04 Spinosad 9 mg/mL Details
Spinosad 9 mg/mL
Spinosad is a TOPICAL SUSPENSION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Allegis Pharmaceuticals, LLC. The primary component is SPINOSAD.
MedlinePlus Drug Summary
Spinosad suspension is used to treat head lice (small insects that attach themselves to the scalp) in adults and children 6 months of age and older. It is also used to treat scabies (mites that attach themselves to the skin) in adults and children 4 years of age and older. Spinosad is in a class of medications called pediculicides. It works by killing the lice and mites.
Related Packages: 28595-0570-04Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Spinosad Topical
Product Information
| NDC | 28595-0570 |
|---|---|
| Product ID | 28595-570_fd005151-3669-d822-e053-6394a90a933d |
| Associated GPIs | 90900048001820 |
| GCN Sequence Number | 066988 |
| GCN Sequence Number Description | spinosad SUSPENSION 0.9 % TOPICAL |
| HIC3 | Q5R |
| HIC3 Description | TOPICAL ANTIPARASITICS |
| GCN | 29436 |
| HICL Sequence Number | 037349 |
| HICL Sequence Number Description | SPINOSAD |
| Brand/Generic | Generic |
| Proprietary Name | Spinosad |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | spinosad |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | SUSPENSION |
| Route | TOPICAL |
| Active Ingredient Strength | 9 |
| Active Ingredient Units | mg/mL |
| Substance Name | SPINOSAD |
| Labeler Name | Allegis Pharmaceuticals, LLC |
| Pharmaceutical Class | Pediculicide [EPC] |
| DEA Schedule | n/a |
| Marketing Category | NDA AUTHORIZED GENERIC |
| Application Number | NDA022408 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 28595-0570-04 (28595057004)
| NDC Package Code | 28595-570-04 |
|---|---|
| Billing NDC | 28595057004 |
| Package | 1 BOTTLE, PLASTIC in 1 CARTON (28595-570-04) / 120 mL in 1 BOTTLE, PLASTIC |
| Marketing Start Date | 2014-06-25 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |